The comparative anti-oxidant and anti-inflammatory efficacy of postbiotics and probiotics through Nrf-2 and NF-kB pathways in DSS-induced colitis model

Sci Rep. 2024 May 21;14(1):11560. doi: 10.1038/s41598-024-62441-0.

Abstract

IBD is a disorder which could be caused by oxidative stress. This investigation aims to determine if probiotics and postbiotics can control oxidative stress and inflammation and compare the effectiveness of these two probiotic and postbiotic mixtures of substances. 88 strains of Lactobacillus and Bifidobacterium were tested for antioxidant activity. Male wild-type C57BL/6 mice were divided into four experimental groups, namely high fat diet (HFD) + PBS, HFD + DSS, HFD + DSS + 109 cfu/ml of probiotics, and HFD + DSS + 109 cfu/ml of postbiotics. The phenotypical indices and pathological scores were assessed. The expression of genes related to NF-kB and Nrf2 signaling pathways and enzymes associated with oxidant/anti-oxidant activities, and proinflammatory/inflammatory cytokines were assessed. In contrast to the groups exposed to DSS, mice treated with probiotics mixture and postbiotics mixture alongside DSS displayed alleviation of DSS-induced adverse effects on phenotypical characteristics, as well as molecular indices such as the Nrf2 and NF-kB related genes, with a greater emphasis on the postbiotics component. In accordance with the findings of the present investigation, it can be inferred that even in using a high-fat dietary regimen as an inducer of oxidative stress, the emergence of inflammation can be effectively addressed through the utilization of probiotics and, more specifically, postbiotics.

Keywords: Inflammation; Oxidative stress; Postbiotic; Probiotic.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Anti-Inflammatory Agents* / pharmacology
  • Antioxidants* / metabolism
  • Antioxidants* / pharmacology
  • Bifidobacterium
  • Colitis* / chemically induced
  • Colitis* / metabolism
  • Colitis* / microbiology
  • Dextran Sulfate*
  • Diet, High-Fat / adverse effects
  • Disease Models, Animal*
  • Lactobacillus
  • Male
  • Mice
  • Mice, Inbred C57BL*
  • NF-E2-Related Factor 2* / metabolism
  • NF-kappa B* / metabolism
  • Oxidative Stress* / drug effects
  • Probiotics* / pharmacology
  • Signal Transduction* / drug effects

Substances

  • Nfe2l2 protein, mouse